Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

947 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NF-kappaB in inflammatory bowel disease.
Atreya I, Atreya R, Neurath MF. Atreya I, et al. Among authors: neurath mf. J Intern Med. 2008 Jun;263(6):591-6. doi: 10.1111/j.1365-2796.2008.01953.x. J Intern Med. 2008. PMID: 18479258 Free article. Review.
Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo.
Atreya R, Mudter J, Finotto S, Müllberg J, Jostock T, Wirtz S, Schütz M, Bartsch B, Holtmann M, Becker C, Strand D, Czaja J, Schlaak JF, Lehr HA, Autschbach F, Schürmann G, Nishimoto N, Yoshizaki K, Ito H, Kishimoto T, Galle PR, Rose-John S, Neurath MF. Atreya R, et al. Among authors: neurath mf. Nat Med. 2000 May;6(5):583-8. doi: 10.1038/75068. Nat Med. 2000. PMID: 10802717
Chemokines in inflammatory bowel diseases.
Atreya R, Neurath MF. Atreya R, et al. Among authors: neurath mf. Dig Dis. 2010;28(3):386-94. doi: 10.1159/000320392. Epub 2010 Sep 30. Dig Dis. 2010. PMID: 20926862
[Endoscopic therapies in inflammatory bowel diseases].
Neumann H, Neurath MF, Atreya R. Neumann H, et al. Among authors: neurath mf. MMW Fortschr Med. 2015 Jun;157(12):63-6. doi: 10.1007/s15006-015-3283-z. MMW Fortschr Med. 2015. PMID: 26099411 German. No abstract available.
Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study.
Stallmach A, Langbein C, Atreya R, Bruns T, Dignass A, Ende K, Hampe J, Hartmann F, Neurath MF, Maul J, Preiss JC, Schmelz R, Siegmund B, Schulze H, Teich N, von Arnim U, Baumgart DC, Schmidt C. Stallmach A, et al. Among authors: neurath mf. Aliment Pharmacol Ther. 2016 Dec;44(11-12):1199-1212. doi: 10.1111/apt.13813. Epub 2016 Oct 7. Aliment Pharmacol Ther. 2016. PMID: 27714831 Free article.
947 results